These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6127944)

  • 21. Rate and time dependent effects of D-sotalol on the monophasic action potential after sudden increase of the heart rate.
    Melichercik J; Brachmann J; Schöls W; Hilbel T; Beyer T; Kübler W
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):65-72. PubMed ID: 9990602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Class III action of beta-blocking agents.
    Taggart P; Donaldson R; Abed J; Nashat F
    Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol.
    Fiset C; Drolet B; Hamelin BA; Turgeon J
    J Pharmacol Exp Ther; 1997 Oct; 283(1):148-56. PubMed ID: 9336319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (+)-sotalol causes significant occupation of beta-adrenoceptors at concentrations that prolong cardiac repolarization.
    Reid J; Duker G; Almgren O; Nerme V
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):215-20. PubMed ID: 2160616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of chronic oral therapy with atenolol and sotalol on ventricular monophasic action potential duration and effective refractory period.
    Way BP; Forfar JC; Cobbe SM
    Am Heart J; 1988 Sep; 116(3):740-6. PubMed ID: 3046277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiologic properties of sotalol and d-sotalol. A current view.
    Touboul P
    Eur Heart J; 1993 Nov; 14 Suppl H():24-9. PubMed ID: 7904935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs.
    Gomoll AW; Bartek MJ
    Eur J Pharmacol; 1986 Dec; 132(2-3):123-35. PubMed ID: 2880732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sotalol on human atrial action potential duration and refractoriness: cycle length dependency of class III activity.
    Hayward RP; Taggart P
    Cardiovasc Res; 1986 Feb; 20(2):100-7. PubMed ID: 3708643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of acute global low-flow ischemia on triggered arrhythmias in d-sotalol-induced long Q-T intervals in perfused rabbit hearts.
    Spear JF; Moore EN
    J Cardiovasc Pharmacol; 2001 Feb; 37(2):196-208. PubMed ID: 11210002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties.
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Am Heart J; 1984 May; 107(5 Pt 1):888-95. PubMed ID: 6720518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency dependent effects of d-sotalol and amiodarone on the action potential duration of the human right ventricle.
    Huikuri HV; Yli-Mäyry S
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2103-7. PubMed ID: 1279607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease.
    Kopelman HA; Woosley RL; Lee JT; Roden DM; Echt DS
    Am J Cardiol; 1988 May; 61(13):1006-11. PubMed ID: 3284316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
    Takahara A; Sugiyama A; Hashimoto K
    Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute prolongation of myocardial refractoriness by sotalol.
    Bennett DH
    Br Heart J; 1982 Jun; 47(6):521-6. PubMed ID: 7082500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog.
    Allely MC; Ungar A
    Br J Pharmacol; 1985 Oct; 86(2):393-8. PubMed ID: 2864972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoproterenol antagonizes drug-induced prolongation of action potential duration in humans.
    Newman D; Dorian P; Feder-Elituv R
    Can J Physiol Pharmacol; 1993; 71(10-11):755-60. PubMed ID: 8143233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.
    Funck-Brentano C; Kibleur Y; Le Coz F; Poirier JM; Mallet A; Jaillon P
    Circulation; 1991 Feb; 83(2):536-45. PubMed ID: 1846784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiologic effects of d-sotalol in humans.
    McComb JM; McGovern B; McGowan JB; Ruskin JN; Garan H
    J Am Coll Cardiol; 1987 Jul; 10(1):211-7. PubMed ID: 3597990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Divergent effect of acute ventricular dilatation on the electrophysiologic characteristics of d,l-sotalol and flecainide in the isolated rabbit heart.
    Eckardt L; Haverkamp W; Göttker U; Madeja M; Johna R; Borggrefe M; Breithardt G
    J Cardiovasc Electrophysiol; 1998 Apr; 9(4):366-83. PubMed ID: 9581953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological effects of sotalol--just another beta blocker?
    Nathan AW; Hellestrand KJ; Bexton RS; Ward DE; Spurrell RA; Camm AJ
    Br Heart J; 1982 Jun; 47(6):515-20. PubMed ID: 7082499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.